4.7 Article

2-Deoxy-D-ribose induces ferroptosis in renal tubular epithelial cells via ubiquitin-proteasome system-mediated xCT protein degradation

Journal

FREE RADICAL BIOLOGY AND MEDICINE
Volume 208, Issue -, Pages 384-393

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2023.08.027

Keywords

2-Deoxy; D -ribose; Ferroptosis; System xc; Renal tubular epithelial cells; Ubiquitin-proteasome system

Ask authors/readers for more resources

The study found that 2-deoxy-D-ribose (dRib) induces ferroptosis in renal tubular epithelial cells by degrading xCT protein through the ubiquitin-proteasome system, resulting in reduced cystine uptake.
Ferroptosis is a novel form of cell death triggered by iron-dependent lipid peroxidation. Recent findings suggest that inhibiting system xc-induces ferroptosis by reducing intracellular cystine levels, and that ferroptosis in renal tubular epithelial cells (RTECs) contributes to acute kidney injury (AKI) and diabetic nephropathy. Moreover, 2-deoxy-D-ribose (dRib) has been shown to inhibit cystine uptake through xCT, the functional unit of system xc-, in ll-cells. This study aimed to investigate if dRib induces ferroptosis in RTECs and identify the underlying mechanisms.dRib treatment reduced cystine uptake and glutathione (GSH) content, and increased intracellular levels of malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), lipid reactive oxygen species (ROS), and cell death in both NRK-52E cells and primary cultured RTECs. However, treatment with inhibitors of ferroptosis, such as defer-oxamine (DFO), ferrostatin-1 (Fer-1), and liproxstatin-1 (Lip-1), counteracted the effects of dRib on GSH, MDA, 4-HNE, and lipid ROS levels, as well as cell death. Additionally, 2-mercaptoethanol (2-ME) treatment or xCT gene overexpression protected against dRib-induced changes. Moreover, transmission electron microscopy revealed dRib-induced mitochondrial shrinkage, decrease in cristae number, and outer membrane rupture. Furthermore, dRib treatment upregulated the expression of genes associated with ferroptosis, and downregulated xCT protein expression. The decrease in xCT protein caused by dRib was consistently observed even when treated with the protein synthesis inhibitor cycloheximide. However, treatment with the proteasome inhibitor MG132 reversed the dRib-induced decrease in xCT protein expression. Additionally, dRib increased xCT protein ubiquitination. Overall, dRib induces ferroptosis in RTECs by degrading xCT protein through ubiquitin-proteasome system (UPS), resulting in reduced intracellular cystine uptake. Therefore, targeting the regulation of system xc-through UPS could be a potential therapeutic approach for AKI and diabetic nephropathy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available